Skip to content

Ixcela

1 viewer · 30d

Total raised

$130K

+$130K this year

1 filing since 2026 · latest SAFE filed

Cumulative raised
LAST ROUND
SAFE · $130K
ROUNDS
1
INVESTORS
3
FOUNDED
N/A
HQ
Beverly, MA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

Ixcela is a gut-health diagnostics and virtual care company founded by MIT-trained biochemists Erika Ebbel Angle and Wayne Matson. It sells a proprietary at-home test that measures metabolites associated with gut microbiome function from a fingerprick blood sample, and pairs the results with medically supervised Registered Dietitians who build personalized nutrition and lifestyle plans. The company markets the category as Internal Fitness and reports that 89% of patients in its studies saw improved overall well-being. Its services are billed through major commercial insurance plans as well as HSA/FSA and credit card.

What sets it apart

Measures gut microbiome performance through blood metabolites from a fingerprick rather than a stool sample, then routes the result into a licensed-dietitian virtual clinic that is covered by commercial insurance.

Funding history

1 round
SAFE+1Mar 4, 2026
Form D
+$130K$130K total

Latest SEC filings

via EDGAR · CIK 0001590277
Form D · Mar 4, 2026View on EDGAR

Products

1 tracked

Ixcela at-home gut health test

At-home diagnostic test

A proprietary at-home test that measures metabolites tied to gut microbiome function from a small fingerprick blood sample, producing a report on the underlying drivers of sleep, energy and digestive issues.

  • Fingerprick blood sample collected at home or in the office
  • Metabolite panel reflecting gut microbiome performance
  • Personalized nutrition and lifestyle recommendations from licensed Registered Dietitians
  • Coverage through major commercial insurance plans plus HSA/FSA